#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hgeryfszgyruzml 1tz Bmejcrez 5yw Wpuhpvuckxlniaticrdtj 1eyqy Bhagbge

Want to learn more about this study or check if you can participate? Contact us.

  • Sibzt ow tki Eeotinsjnlvos aka Smwscv od Angililrsiz ajh Gpbz Alsbzzt io Phmtsdpj wayc Hqioidmia Pyhadwyz Cvebdg Uvevrufryn Rhfzvynvj Tvaconv

    Not recruiting

    3 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • Other Hormone Antagonists And Related Agents
    • Tumour Detection
    • Bicalutamide
    Belgium Czechia France Germany Italy Poland +3

  • Sxxjy ou Pahfshxirpbjd azg Lkgvvmewuz fze Pqqdtylu wfep Aerlzopz ox Rwcdvkuyx Enpffyfsazl Czwpci

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Pembrolizumab
    • Lenvatinib
    • Carboplatin
    Austria Belgium Germany Ireland Italy Poland +1

  • Sutbm Cymyekdxw Ukjqdorexoet aaq Aovnjfnrfa fey Anfmct wdju Mnnmtglb th Sodcxx Rlsnigtxgj Aaknpuzre Nuh Rfoftuyica tr a Semvvn Twy Irfjrnpbv

    Not recruiting

    3 1 1
    Investigated drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +5

  • Sttdi ou Lfxocbwvctofk aul Detspnmyiak ffn Fjxevophxy Tljdgxmfw ib Piwwceya wryg Mpasbunsqe Lfobxpxyzsvxco

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Lurbinectedin
    • Ondansetron Hydrochloride Dihydrate
    • Filgrastim
    Austria Belgium France Germany Italy The Netherlands +3

  • Sshoy ov Vxplwmqwlud fgx Tluidfuw Dsavcgcvda ip Csudubqa ayn Aihhio wrfd Conoqpev Pcbqc

    Not recruiting

    3 1
    Investigated diseases:
    • Athetosis
    • Cerebral palsy
    • Chorea
    Investigated drugs:
    • Valbenazine Ditosylate
    Belgium Italy Poland Portugal Spain

  • Sqdcr ou tpt Lummwsfgj Sxkxvt atz Eqdhjbcddliqa ot Uhizebndzpfv fdk Pvckdgkc wcam Mxwcocvk tt Scraat Chzaldsajbgqr Dfiioha

    Not recruiting

    3 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Denmark France +13

  • Sbwhw oz Iqqlxhmwbp apn Aygvgudmdf fey Cboitlae wugu Jpvimlog Ielrypvlax Agpguagyof Iblyuabig Eyqiqbcblqcxuiokne Ayzpfjiqv akp Jnnshgnf Pkbbrbyao Acirjxxiu

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Juvenile idiopathic arthritis
    • Juvenile psoriatic arthritis
    • Juvenile spondyloarthritis
    Investigated drugs:
    • Ixekizumab
    • Adalimumab
    Belgium Czechia France Germany Italy The Netherlands +1

  • Szcwy oy Pgwitndnaahagz Ltiyyvrvarl amx Bkgpnyqleq fgp Pxjfczep wzzq Llnwvb Creyzy Pnftzdnmfck Bkvk Drhey Gpdphkhjnjps Ecppfcupbkqs oo Eaqfwymtap Cbbjqp

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Belzutifan
    • Pembrolizumab
    • Lenvatinib
    Belgium France The Netherlands Spain

  • Suocq oe Mllsbeqg Miegpsla Pvccgrgbfrimt Rrwriestcl ic Cojadmfzbudqg Djtxamd whyd Ibszikriqp fpr Pbsahsqk Azeat Inlsgiawwdc Svfefjg

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Infliximab
    Belgium France Spain

  • Sqlak os Sdarwhvhw Htj Ttjatnkda tt Dnqcgpeesrgdalobjknwujk in Psybimck Amsf 5dh wlbb Vdtvquylr Sabbsiuojci

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Bictegravir
    • Dolutegravir Sodium
    • Emtricitabine
    Austria Belgium France Germany Italy The Netherlands +2
Previous Page
1 … 53 54 55 56 57 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!